RARA and acute promyelocytic leukemia: It should also be noted that the same ATRA–ATO–based treatment protocols used for classical PML::RARA–positive APL are not applicable to APL variants, which usually require intensive chemotherapy and novel targeted therapies guided by molecular diagnostics [33].